A detailed history of Raleigh Capital Management Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 80 shares of TECH stock, worth $5,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 65 23.08%
Holding current value
$5,974
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$62.12 - $84.15 $931 - $1,262
15 Added 23.08%
80 $5,000
Q1 2024

May 13, 2024

BUY
$65.98 - $77.09 $3,299 - $3,854
50 Added 333.33%
65 $4,000
Q4 2023

Feb 21, 2024

BUY
$52.83 - $78.22 $792 - $1,173
15 New
15 $1,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.93B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.